Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...

This week, Dexcom became the first medical device company to integrate generative AI into a continuous glucose monitor. The company added generative AI to its Stelo glucose monitor, which it began ...

In an era where proactive health management is more critical than ever, Stelo emerges as a groundbreaking solution for glucose monitoring. Specifically designed for pre-diabetics and those at risk for ...